WallStreetZenWallStreetZen

NASDAQ: INZY
Inozyme Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for INZY

Based on 3 analysts offering 12 month price targets for Inozyme Pharma Inc.
Min Forecast
$15.00+294.22%
Avg Forecast
$18.00+373.06%
Max Forecast
$23.00+504.47%

Should I buy or sell INZY stock?

Based on 3 analysts offering ratings for Inozyme Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INZY stock forecasts and price targets.

INZY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-08
lockedlocked$00.00+00.00%2023-09-08
lockedlocked$00.00+00.00%2023-08-08

1 of 1

Forecast return on equity

Is INZY forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is INZY forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

INZY revenue forecast

What is INZY's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$17.9M
Avg 2 year Forecast
$163.9M
Avg 3 year Forecast
$392.3M

INZY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INZY$3.81$18.00+373.06%Buy
OVID$3.35$6.00+79.10%Strong Buy
RPHM$7.00$27.67+295.24%Strong Buy
RENB$3.49N/AN/A
FHTX$5.63$15.00+166.43%Buy
View Top Biotech Stocks

Inozyme Pharma Stock Forecast FAQ

Is Inozyme Pharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: INZY) stock is to Buy INZY stock.

Out of 3 analysts, 0 (0%) are recommending INZY as a Strong Buy, 3 (100%) are recommending INZY as a Buy, 0 (0%) are recommending INZY as a Hold, 0 (0%) are recommending INZY as a Sell, and 0 (0%) are recommending INZY as a Strong Sell.

If you're new to stock investing, here's how to buy Inozyme Pharma stock.

What is INZY's revenue growth forecast for 2026-2028?

(NASDAQ: INZY) Inozyme Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Inozyme Pharma's revenue in 2023 is $0.On average, 3 Wall Street analysts forecast INZY's revenue for 2026 to be $1,106,752,604, with the lowest INZY revenue forecast at $169,224,450, and the highest INZY revenue forecast at $2,301,205,470. On average, 3 Wall Street analysts forecast INZY's revenue for 2027 to be $10,122,154,272, with the lowest INZY revenue forecast at $6,076,639,996, and the highest INZY revenue forecast at $14,011,043,291.

In 2028, INZY is forecast to generate $24,230,594,263 in revenue, with the lowest revenue forecast at $15,521,711,187 and the highest revenue forecast at $32,939,477,338.

What is INZY's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: INZY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is INZY's Price Target?

According to 3 Wall Street analysts that have issued a 1 year INZY price target, the average INZY price target is $18.00, with the highest INZY stock price forecast at $23.00 and the lowest INZY stock price forecast at $15.00.

On average, Wall Street analysts predict that Inozyme Pharma's share price could reach $18.00 by Nov 8, 2024. The average Inozyme Pharma stock price prediction forecasts a potential upside of 373.06% from the current INZY share price of $3.81.

What is INZY's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: INZY) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.